葛根素注射液与丁苯肽联合治疗脑梗死的效果  

The Clinical Value of Puerarin Injection Combined With Butylphthalide in the Treatment of Cerebral Infarction

作　　者：齐丹[1] QI Dan(Department of Neurology,Heilongjiang Provincial Hospital,Harbin Heilongjiang 150001,China)

机构地区：[1]黑龙江省医院神经内科,黑龙江哈尔滨150001

出　　处：《中国卫生标准管理》2020年第13期62-64,共3页China Health Standard Management

摘　　要：目的探讨脑梗死患者采取丁苯肽联合葛根素注射液治疗的临床价值。方法收集92例2018年12月—2019年6月在本院就诊的脑梗死患者随机分成对照组和观察组,前一组实施常规治疗,后一组实施丁苯肽联合葛根素注射液治疗,对比两组临床效果。结果观察组比对照组神经缺损程度和日常生活能力水平更优(P<0.05);观察组比对照组全血黏度、纤维蛋白质原及红细胞积压更优(P<0.05);观察组(93.48%)比对照组(76.09%)治疗有效率更高(P<0.05)。结论脑梗死患者采取丁苯肽联合葛根素注射液治疗,能够改善血液流变学指标,降低不良反应发生率,提升治疗总有效率。Objective To explore the clinical value of butylphenin combined with Puerarin Injection in patients with cerebral infarction.Methods 92 patients with cerebral infarction who were treated in our hospital from December 2018 to June 2019 were randomly divided into control group and observation group.The former group was treated with routine therapy,the latter group was treated with butylphenyl peptide and puerarin injection,and the clinical effects of the two groups were compared.Results The degree of nerve defect and the level of daily living ability of the observation group were better than those of the control group(P<0.05);the whole blood viscosity,fibrinogen and red blood cell overstock of the observation group were better than those of the control group(P<0.05);the treatment efficiency of the observation group(93.48%)was higher than that of the control group(76.09%)(P<0.05).Conclusion The treatment of brain infarction with butylphthalide and puerarin injection can improve the hemorheology index,reduce the incidence of adverse reactions and improve the total effective rate.

关 键 词：脑梗死 丁苯肽 葛根素注射液 治疗效果 神经功能缺损 生活能力 

分 类 号：R743[医药卫生—神经病学与精神病学]